Clinical Trials Directory

Trials / Conditions / Breast Lobular Carcinoma In Situ

Breast Lobular Carcinoma In Situ

10 registered clinical trials studyying Breast Lobular Carcinoma In Situ — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingLow Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT06195306
National Cancer Institute (NCI)Phase 2
RecruitingFinding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT06184750
National Cancer Institute (NCI)Phase 2
RecruitingAcolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk f
NCT05941520
National Cancer Institute (NCI)Phase 2
RecruitingImpact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT05178498
Ohio State University Comprehensive Cancer Center—
RecruitingAdding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic W
NCT05755269
Mayo Clinic—
TerminatedOral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increa
NCT04570956
Mayo ClinicPhase 2
CompletedEMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
NCT05086705
Ohio State University Comprehensive Cancer CenterN/A
TerminatedAbemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Ca
NCT03979508
Mayo ClinicPhase 2
Active Not RecruitingPhase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
NCT03317405
National Cancer Institute (NCI)Phase 1
CompletedBexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
NCT03323658
National Cancer Institute (NCI)Phase 1